Trupanion, Inc. (NASDAQ:TRUP) Receives Average Recommendation of “Hold” from Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have received an average rating of “Hold” from the six research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $41.60.

A number of research firms recently commented on TRUP. Stifel Nicolaus set a $28.00 price objective on Trupanion in a research note on Friday, June 26th. Cantor Fitzgerald lowered their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday. Bank of America decreased their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st.

Insider Buying and Selling at Trupanion

In other Trupanion news, COO John R. Gallagher sold 3,603 shares of Trupanion stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the completion of the sale, the chief operating officer owned 33,065 shares in the company, valued at $717,179.85. The trade was a 9.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the completion of the sale, the chief financial officer directly owned 2,081 shares in the company, valued at $46,156.58. This represents a 74.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 17,807 shares of company stock worth $395,482 in the last 90 days. 5.58% of the stock is owned by company insiders.

Hedge Funds Weigh In On Trupanion

Several hedge funds and other institutional investors have recently modified their holdings of the company. Millennium Management LLC raised its stake in shares of Trupanion by 185.8% in the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after acquiring an additional 402,421 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Trupanion by 116.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock valued at $17,826,000 after purchasing an additional 256,559 shares during the period. Two Sigma Investments LP raised its stake in shares of Trupanion by 3,201.0% during the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after purchasing an additional 217,634 shares during the period. Polar Capital Holdings Plc lifted its position in shares of Trupanion by 13.5% during the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after purchasing an additional 175,000 shares in the last quarter. Finally, Marshall Wace LLP lifted its position in shares of Trupanion by 15.5% during the third quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock worth $52,462,000 after purchasing an additional 163,101 shares in the last quarter.

Trupanion Stock Performance

Shares of TRUP opened at $25.47 on Thursday. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The stock has a market cap of $1.11 billion, a P/E ratio of 43.17 and a beta of 1.39. The company has a 50-day moving average of $23.78 and a two-hundred day moving average of $27.39. Trupanion has a 12-month low of $21.16 and a 12-month high of $57.00.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. The firm had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.Trupanion’s revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.03) EPS. As a group, research analysts predict that Trupanion will post 0.54 EPS for the current fiscal year.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.